Profit margins, page-41

"Lets assume there is 12 hospitals in the US are using BTM and the average cost is us$6k this time."

Your assumption is flawed: at the AGM in November it was said that 36 hospitals were currently ordering. So, I think that it's reasonable to assume that several more will have come on board by now. 

Caveat on what follows: sales will vary considerably between hospitals, and from month to month for each. Usage by surgeons within hospitals will also vary as early adopters are watched by others. So, averages at this early stage provide poor guidance.

Nevertheless, given that's where you want to go: from the last announcement on 1HY sales, the last quarter had sales of $2M approx.; that's from approx. 36 hospitals (fewer in October, maybe more in December); and works out to be approx. $20,000 per month per hospital.

So, 50 hospitals at that average delivers $1M per month. Breakeven. If it hasn't happened already it should do so before end of FY.

I think that you should focus on the end goal and the rate of sales growth towards that end. There is a sales potential of US$300M - $400M and about $300M in Europe. If BTM is "well-established" in that space it's an awful lot of sales, and they think they can do it "in the next few years".

Draw a line from now to 2022 and sales of, say, $200M pa. You know you want to, just do it.